Literature DB >> 27150649

Perioperative Complications and Long-Term Outcomes After Bypasses in Adults with Moyamoya Disease: A Systematic Review and Meta-Analysis.

Hai Sun1, Christopher Wilson2, Alp Ozpinar3, Sam Safavi-Abbasi1, Yan Zhao2, Peter Nakaji1, John E Wanebo1, Robert F Spetzler4.   

Abstract

BACKGROUND: Surgical revascularization for adults with moyamoya disease (MD) includes direct, indirect, or combination bypasses. It is unclear which provides the best outcomes. We sought to determine the best surgical management for adults with MD by comparing perioperative complications and long-term outcomes among 3 bypass types.
METHODS: Literature databases were searched for articles reporting revascularization bypass outcomes for adults with MD. A pooled analysis of all qualified studies and meta-analysis using only studies reporting direct comparisons of 2 bypass types were performed. Overall odds ratios (ORs) comparing 2 bypass types were computed and publication bias was assessed. Rates of perioperative and long-term hemorrhage and ischemia and favorable outcomes were compared.
RESULTS: Forty-seven studies were analyzed; 8 had level 1 or 2 evidence. Pooled analyses showed that perioperative hemorrhage rates were significantly (P = 0.02) lower with indirect compared with direct (OR, 0.03; 95% confidence interval [CI], 0.002-0.55) or combined (OR, 0.03; 95% CI, 0.002-0.53) bypasses. Meta-analysis showed that direct bypass was better at preventing long-term hemorrhage than was indirect bypass (OR, 0.26; 95% CI, 0.09-0.79; P = 0.02). Pooled analyses showed that direct is significantly better (P < 0.01) than indirect (OR, 0.51; 95% CI, 0.33-0.77) and combined (OR, 0.47; 95% CI, 0.31-0.72) bypasses in preventing long-term ischemia. Meta-analysis showed that direct was better than indirect bypass in producing long-term favorable outcomes (OR, 2.62; 95% CI, 1.19-5.79; P = 0.02), and the pooled analysis showed that combined bypass was better than indirect bypass in producing long-term favorable outcomes (OR, 1.26; 95% CI, 1.03-1.54; P = 0.02).
CONCLUSIONS: Overall, our analyses suggest that direct bypass with or without indirect augmentation provides the best outcomes for adults with MD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult moyamoya disease; Bypass; Cerebral blood flow; Cerebral ischemia; Intracranial hemorrhage; Surgical revascularization

Mesh:

Year:  2016        PMID: 27150649     DOI: 10.1016/j.wneu.2016.04.083

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  8 in total

1.  Time Course of Neoangiogenesis After Indirect Bypass Surgery for Moyamoya Disease : Comparison of Short-term and Long-term Follow-up Angiography.

Authors:  Yahui Zhao; Junlin Lu; Qian Zhang; Yan Zhang; Dong Zhang; Rong Wang; Yuanli Zhao
Journal:  Clin Neuroradiol       Date:  2018-12-03       Impact factor: 3.649

Review 2.  Surgical Treatment of Adult Moyamoya Disease.

Authors:  Si Un Lee; Chang Wan Oh; O-Ki Kwon; Jae Seung Bang; Seung Pil Ban; Hyoung Soo Byoun; Tackeun Kim
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.598

3.  Combined direct and indirect superficial temporal artery-to-middle cerebral artery bypass with a hinged bone flap: how I do it.

Authors:  Robert C Rennert; Karol P Budohoski; Ramesh Grandhi; William T Couldwell
Journal:  Acta Neurochir (Wien)       Date:  2022-10-24       Impact factor: 2.816

Review 4.  A Recent Update of Clinical and Research Topics Concerning Adult Moyamoya Disease.

Authors:  Jin Pyeong Jeon; Jeong Eun Kim
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

5.  Remote ischemic conditioning for the treatment of ischemic moyamoya disease.

Authors:  Jia-Yue Ding; Shu-Ling Shang; Zhi-Shan Sun; Karam Asmaro; Wei-Li Li; Qi Yang; Yu-Chuan Ding; Xun-Ming Ji; Ran Meng
Journal:  CNS Neurosci Ther       Date:  2019-12-08       Impact factor: 5.243

Review 6.  Surgical techniques and indications for treatment of adult moyamoya disease.

Authors:  Vincent N Nguyen; Kara A Parikh; Mustafa Motiwala; L Erin Miller; Michael Barats; Camille Milton; Nickalus R Khan
Journal:  Front Surg       Date:  2022-08-19

7.  Quantitative Angiographic Hemodynamic Evaluation After Revascularization Surgery for Moyamoya Disease.

Authors:  Yu Chen; Li Ma; Shuo Yang; Jan-Karl Burkhardt; Junlin Lu; Xun Ye; Weijian Jiang; Zeguang Ren; Rong Wang; Xiaolin Chen; Yuanli Zhao
Journal:  Transl Stroke Res       Date:  2020-02-13       Impact factor: 6.800

8.  Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease.

Authors:  Chang Hwan Pang; Won-Sang Cho; Hyun-Seung Kang; Jeong Eun Kim
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.